Efficacy and safety of extended-interval dosing of natalizumab in multiple sclerosis: a systematic review and meta-analysis with subgroup evaluation. - Hammadeh BM; Sameer S; Alnajjar M; Abu-Issa I; Alhallaq MS; Ghazi M; Badr A; Shawawrah M (Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026)